Hence, it was suggested that anti-U1RNP might have a protective effect in SSc-associated PAH, although these findings were not statistically significant [hazard ratio 0.47 (95% confidence interval: 0.20–1.11), P = 0.085]. Here, SNRNP70 is linked to systemic sclerosis.